Shaily Engineering Plastics Q1 FY27 Earnings Call Transcript Released
Shaily Engineering Plastics reported Q1 FY27 consolidated revenue of ₹281 crore, up 14% YoY. Healthcare segment revenue grew 85% to ₹142 crore. EBITDA increased 18% to ₹83 crore, and PAT grew 17% to ₹48 crore. The company is expanding pen injector capacity to 75 million pens per annum by September and is confident in exceeding its 36 million pen guidance.
The announcement details significant revenue growth, expansion of key business segments (Healthcare), capacity enhancements, and positive future outlook, which are material factors for investors.
The company reported strong year-on-year growth in revenue, EBITDA, and PAT. The healthcare segment showed exceptional growth, and management expressed confidence in exceeding future targets, indicating a positive outlook.
Shaily Engineering Plastics Limited (SEPL) has released the transcript of its Q1 FY27 earnings conference call, which was held on August 10, 2026. The call, attended by Managing Director Amit Sanghvi and Chief Strategy Officer Sanjay Shah, discussed the company's operational and financial performance for the quarter ended June 30, 2026.
Despite a challenging global operating environment marked by geopolitical uncertainty, supply chain disruptions, and volatile commodity prices, Shaily Engineering Plastics reported robust performance. The company highlighted its strategic focus on quality and innovation, particularly in its healthcare segment. Six of its eight device platforms are now commercialized globally, with early successes including generic Semaglutide launches and tentative U.S. FDA approval for generic Semaglutide.
The company has appointed dedicated heads of business development for Europe and North America to drive growth in these priority markets. The healthcare segment saw significant year-on-year revenue growth of 85% to ₹142 crore, contributing 51% of consolidated revenue, primarily driven by its pen injector platform for chronic therapies like GLP-1 and insulin. The company expects its additional 25 million pen capacity to be operational by the end of September, increasing total installed capacity to approximately 75 million pens per annum.
The Consumer segment reported revenue of ₹116 crore, affected by softer demand in home furnishings in Europe and the US, though new programs and customer relationships were expanded. The Industrial segment grew by 25% year-on-year to ₹23 crore, supported by new customer additions and opportunities in engineering applications. Consolidated revenue for Q1 FY27 stood at ₹281 crore, a 14% year-on-year increase, with EBITDA growing 18% to ₹83 crore and profit after tax rising 17% to ₹48 crore. EBITDA margin improved to 29.7% and PAT margin to 17.1%.
During the Q&A, management discussed efforts to improve production efficiency for new pen lines, with a target to achieve 80% efficiency before shipping new lines to mitigate ramp-up challenges. They expressed confidence in exceeding the full-year guidance of 36 million pens. Discussions also covered the Consumer Electronics vertical, with plans for a new plant requiring an investment of ₹80-100 crore, and the semiconductor tray business, which will require an initial investment of ₹5 crore. The company is also developing emergency use auto-injectors, reusable auto-injectors, and on-body injectors for oncology treatments, aiming to secure partnerships with global pharmaceutical companies.
What to do with a filing like this
Shaily Engineering Plastics Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shaily Engineering Plastics Limited. Read the original for the full detail.